估计的葡萄糖排放率和发生高尿血的风险:查尔斯的见解
YuanJian Liao1, MingShun Zuo1, Te Xu1
1Department of Urology, The Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, China.
Scientific reports
|November 11, 2025
概括
较高的估计葡萄糖处置率 (eGDR),胰岛素抵抗的标志物,与较低的患上高尿路血症 (HUA) 的风险有关. 这一发现表明,eGDR可以成为HUA预防和管理的有价值指标.
科学领域:
- 内分泌学 在内分泌学.
- 代谢健康 代谢健康
- 流行病学 流行病学
背景情况:
- 超尿路血症 (HUA) 是一个全球性的健康问题,其原因复杂,查指标有限.
- 胰岛素耐药性 (IR) 越来越被认为是导致HUA发展的一个因素.
- 估计的葡萄糖处置率 (eGDR) 作为IR的可靠替代标志物.
研究的目的:
- 调查eGDR与HUA发生率之间的关联.
- 在大型队列中探索eGDR对新发病的HUA的预测价值.
主要方法:
- 在中国健康与退休长度研究中,从基线没有HUA的9091名参与者的数据分析.
- 多变量逻辑回归和受限立方线 (RCS) 模型来评估关联和剂量反应关系.
- 分析ROC曲线,以评估eGDR的预测能力.
主要成果:
- 在79.4个月的中位数随访期间,共发现了306例新的HUA病例.
- RCS分析显示,eGDR和HUA之间存在显著的线性关系.
- 较高的eGDR水平显着与事件HUA风险降低有关,每次eGDR的SD增加都会使HUA风险降低8% (OR 0.92;95% CI 0.86-0.98).
结论:
- 升高的eGDR独立地与患上高尿路血症的风险较低有关.
- eGDR显示出作为HUA预测生物标志物的潜力.
- 针对eGDR可能为HUA预防和干预提供了一个有希望的策略.
相关概念视频
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
178
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
178
Oral Hypoglycemic Agents: Biguanides and Glitazones
568
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
568
Glucose Transporters
27.1K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.1K
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Dipeptidyl Peptidase 4 Inhibitors
570
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
570


